In this context, lipoprotein(a) [Lp(a)] and high sensitivity C-reactive protein (hs-CRP) are of interest given their associations with CVD risk and their roles in pro-inflammatory atherogenic dyslipidemia and general inflammation, respectively. The gene discussed is CRP; the disease is metabolic syndrome.